Moisturising Is Not Enough. Your Skin Barrier Is Broken. That Is Why Eczema Keeps Coming Back.

Every time you apply moisturiser and feel temporary relief, only to wake up with the same dry, inflamed skin two days later — that is not a product failure. That is a structural failure your moisturiser was never designed to fix. Moisturisers hydrate the surface. They do not rebuild a barrier. And if your barrier is broken, eczema will keep returning no matter how diligently you moisturise.

Why Does Eczema Keep Coming Back Even With Regular Moisturising?

The skin barrier — technically the stratum corneum — is not a passive layer of dead skin. It is an active, precisely engineered waterproofing system. Think of it as bricks (skin cells called corneocytes) held together by mortar (a lipid matrix of ceramides, free fatty acids, and cholesterol). That mortar is what keeps moisture in and irritants out.

In eczema-prone skin, this mortar is deficient. A landmark 1991 study by Imokawa et al. published in the Journal of Investigative Dermatology found that eczema patients have significantly reduced ceramide levels — up to 50% lower than in non-eczema skin. Without sufficient ceramides, the barrier cannot hold its structure, and transepidermal water loss (TEWL) increases dramatically. Water evaporates out; allergens, bacteria, and irritants get in.

Standard moisturisers — including many marketed specifically for eczema — primarily function as humectants (attracting water) or occlusives (sealing the surface temporarily). They do not synthesise ceramides. They do not repair the intercellular lipid matrix. So while they may reduce the sensation of tightness and temporarily improve surface appearance, they are not correcting the structural problem. The barrier remains compromised. Eczema returns.

What Is Filaggrin and Why Does It Matter for Eczema?

When filaggrin is absent or reduced, the bricks in that barrier wall lose their cohesion. Corneocytes don't compact properly. The intercellular spaces widen. The result is a physical gap in your skin's first line of defence — and no amount of moisturising adds filaggrin back.

A 2006 study in Nature Genetics identified FLG loss-of-function mutations as the single strongest known genetic risk factor for eczema. Subsequent research published in the British Journal of Dermatology found that filaggrin deficiency creates a cascade: compromised barrier integrity leads to sensitisation to allergens, which then drives the Th2 immune response characteristic of eczema. The evidence suggests the immune reaction may be downstream of barrier failure — not the other way around.

This is the critical insight most eczema treatments miss. They target the immune reaction — with antihistamines, corticosteroids, or immunosuppressants — without addressing why the immune system was triggered in the first place. The allergens entered through a broken barrier. Fix the barrier, and you reduce the antigen load that's driving the immune cascade.

What Does the Lipid Matrix Actually Need to Be Repaired?

A 1996 study by Mao-Qiang, Feingold, and Elias, published in the Journal of Investigative Dermatology, demonstrated that applying ceramides alone, or cholesterol alone, or fatty acids alone actually delayed barrier recovery compared to applying all three in the correct ratio. The skin's barrier synthesis machinery is a competitive, interdependent system. Flooding it with one component suppresses synthesis of the others.

This has direct implications for product choice. Many "ceramide creams" contain ceramide concentrations too low to be physiologically meaningful, or lack the fatty acid and cholesterol cofactors needed for proper incorporation into the lipid matrix. The marketing claims outpace the formulation reality.

Vitamin E plays an important adjunctive role in this process — particularly the tocotrienol form (as opposed to the more commonly used alpha-tocopherol). Tocotrienols, derived from palm oil, have been shown in research to be significantly more bioavailable in skin tissue and more potent as antioxidants at neutralising the oxidative stress that degrades barrier lipids — with studies in Free Radical Biology and Medicine demonstrating that topically applied tocotrienol-rich fractions from palm oil effectively preserve vitamin E levels in skin under oxidative conditions.

REMDII Ultra Sensitive is formulated around both of these principles: it delivers Full-Spectrum Vitamin E — Tocotrienol, Tocopherol, and Beta-carotene from Malaysian palm oil — alongside skin-mimic ceramides at the physiological 3:1:1 ratio.

What This Means for Your Skin

If your eczema keeps returning despite consistent moisturising, the problem is almost certainly structural. Your barrier's lipid matrix is depleted, possibly compounded by filaggrin insufficiency, and your current routine is hydrating a broken surface rather than rebuilding it. You are not failing at skincare. You are using tools designed for a different problem.

This means two things need to change. First, you need a moisturiser that actually delivers barrier-relevant lipids — ceramides, fatty acids, and cholesterol — not just water-binding humectants. Second, you need to support the barrier's oxidative environment with antioxidants that actually penetrate to where barrier synthesis occurs, not just coat the surface.

Understanding that eczema is a structural failure — not a hydration failure — changes what you look for in treatment. Approaches that address the root cause of barrier dysfunction (restoring lipid composition, reducing TEWL, supporting healthy skin cell turnover) produce more durable outcomes than those that manage surface symptoms. When the mortar is restored, the wall holds. When the wall holds, the irritants and allergens that triggered your immune response stay out — and the cycle of flare and recovery breaks.